We thus propose that intrapulmonary delivery of NEIL2, with its dual role in regulating inflammation and DNA repair, has strong potential as a therapeutic agent, especially for chronic inflammatory conditions such as asthma, chronic obstructive pulmonary disease, and other human lung diseases. Here, NEIL2 is linked to lung disorder.